Noble Financial upgraded shares of MariMed (OTCMKTS:MRMD – Free Report) to a strong-buy rating in a research note released on Thursday morning,Zacks.com reports.
MariMed Trading Down 13.4 %
Shares of MRMD stock opened at $0.09 on Thursday. MariMed has a fifty-two week low of $0.07 and a fifty-two week high of $0.34. The company has a 50 day moving average price of $0.11 and a 200 day moving average price of $0.13. The stock has a market capitalization of $33.04 million, a P/E ratio of -2.17 and a beta of 2.75. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.73 and a current ratio of 1.55.
MariMed (OTCMKTS:MRMD – Get Free Report) last posted its quarterly earnings results on Wednesday, March 5th. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). The business had revenue of $39.00 million during the quarter, compared to the consensus estimate of $42.00 million. MariMed had a negative net margin of 10.97% and a negative return on equity of 2.75%.
About MariMed
MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.
Read More
- Five stocks we like better than MariMed
- Following Congress Stock Trades
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- What Are Dividends? Buy the Best Dividend Stocks
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- How to Short a Stock in 5 Easy Steps
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
